SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Víctor G Martínez, Noelia M Canseco, Laura Hidalgo, Jaris Valencia, Ana Entrena, Lidia M Fernández-Sevilla, Carmen Hernández-López, Rosa Sacedón, Angeles Vicente, Alberto Varas, A discrete population of IFN λ-expressing BDCA3hi dendritic cells is present in human thymus, Immunology and Cell Biology, 2015,

    CrossRef

  2. 2
    N. McGovern, J. K. Y. Chan, F. Ginhoux, Dendritic cells in humans--from fetus to adult, International Immunology, 2015, 27, 2, 65

    CrossRef

  3. 3
    Mélanie Durand, Elodie Segura, The Known Unknowns of the Human Dendritic Cell Network, Frontiers in Immunology, 2015, 6,

    CrossRef

  4. 4
    Stacy M. Horner, Activation and Evasion of Antiviral Innate Immunity by Hepatitis C Virus, Journal of Molecular Biology, 2014, 426, 6, 1198

    CrossRef

  5. 5
    Charles-Antoine Dutertre, Lin-Fa Wang, Florent Ginhoux, Aligning bona fide dendritic cell populations across species, Cellular Immunology, 2014, 291, 1-2, 3

    CrossRef

  6. 6
    Yoshihiko Aoki, Masaya Sugiyama, Kazumoto Murata, Sachiyo Yoshio, Masayuki Kurosaki, Satoru Hashimoto, Hiroshi Yatsuhashi, Hideyuki Nomura, Jong-Hon Kang, Tsutomu Takeda, Shigeko Naito, Tatsuji Kimura, Yoko Yamagiwa, Masaaki Korenaga, Masatoshi Imamura, Naohiko Masaki, Namiki Izumi, Masayoshi Kage, Masashi Mizokami, Tatsuya Kanto, Association of serum IFN-λ3 with inflammatory and fibrosis markers in patients with chronic hepatitis C virus infection, Journal of Gastroenterology, 2014,

    CrossRef

  7. 7
    Evelyn van der Aa, Nadine van Montfoort, Andrea M. Woltman, BDCA3+CLEC9A+ human dendritic cell function and development, Seminars in Cell & Developmental Biology, 2014,

    CrossRef

  8. 8
    Sreedhar Chinnaswamy, Genetic Variants at theIFNL3Locus and Their Association with Hepatitis C Virus Infections Reveal Novel Insights into Host-Virus Interactions, Journal of Interferon & Cytokine Research, 2014, 34, 7, 479

    CrossRef

  9. 9
    Elena Tomasello, Emeline Pollet, Thien-Phong Vu Manh, Gilles Uzé, Marc Dalod, Harnessing Mechanistic Knowledge on Beneficial Versus Deleterious IFN-I Effects to Design Innovative Immunotherapies Targeting Cytokine Activity to Specific Cell Types, Frontiers in Immunology, 2014, 5,

    CrossRef

  10. 10
    Nandan S Gokhale, Christine Vazquez, Stacy M Horner, Hepatitis C virus: strategies to evade antiviral responses, Future Virology, 2014, 9, 12, 1061

    CrossRef

  11. 11
    Ian N. Crispe, Immune tolerance in liver disease, Hepatology, 2014, 60, 6
  12. 12
    Sonia Assil, Marlène Dreux, La susceptibilité à l’infection par le virus de l’hépatite C et la réponse antivirale sont modulées par le polymorphisme associé à l’interféron lambda, médecine/sciences, 2014, 30, 12, 1073

    CrossRef

  13. 13
    Andreas Schlitzer, Florent Ginhoux, Organization of the mouse and human DC network, Current Opinion in Immunology, 2014, 26, 90

    CrossRef

  14. 14
    Kentaro Matsuura, Tsunamasa Watanabe, Yasuhito Tanaka, Role of IL28B for chronic hepatitis C treatment toward personalized medicine, Journal of Gastroenterology and Hepatology, 2014, 29, 2
  15. 15
    Tatsuo Kanda, Xia Jiang, Shingo Nakamoto, Masato Nakamura, Tatsuo Miyamura, Shuang Wu, Osamu Yokosuka, Different effects of three interferons L on Toll-like receptor-related gene expression in HepG2 cells, Cytokine, 2013, 64, 2, 577

    CrossRef

  16. 16
    Hugo R. Rosen, Emerging concepts in immunity to hepatitis C virus infection, Journal of Clinical Investigation, 2013, 123, 10, 4121

    CrossRef

  17. 17
    Adelle P McFarland, Stacy M Horner, Abigail Jarret, Rochelle C Joslyn, Eckart Bindewald, Bruce A Shapiro, Don A Delker, Curt H Hagedorn, Mary Carrington, Michael Gale, Ram Savan, The favorable IFNL3 genotype escapes mRNA decay mediated by AU-rich elements and hepatitis C virus–induced microRNAs, Nature Immunology, 2013, 15, 1, 72

    CrossRef